COVID-19 Impact on Tuberculosis Therapeutics Market, Global Research Reports 2020-2021

Publisher Name :
Date: 21-May-2020
No. of pages: 96
Inquire Before Buying

This report covers market size and forecasts of Tuberculosis Therapeutics, including the following market information:

- Global Tuberculosis Therapeutics Market Size, 2019-2021, and 2020 (quarterly data), (US$ Million)

- Global Tuberculosis Therapeutics Market Size by Type and by Application, 2019-2021, and 2020 (quarterly data), (US$ Million)

- Global Tuberculosis Therapeutics Market Size by Region (and Key Countries), 2019-2021, and 2020 (quarterly data), (US$ Million)

- Global Tuberculosis Therapeutics Market Size by Company, 2019- 2020 (quarterly data), (US$ Million)

Key market players

Major competitors identified in this market include Aventis Pharmaceuticals, Sanofi -Aventis, Versapharma Incorporated, Sigma Pharmaceutical Pty, Novartis AG, Hoffmann-La Roche, Bayer Health Care, etc.

Based on the Region:

- Asia-Pacific (China, Japan, South Korea, India and ASEAN)

- North America (US and Canada)

- Europe (Germany, France, UK and Italy)

- Rest of World (Latin America, Middle East & Africa)

Based on the Type:

- Isoniazid

- Rifampin

- Pyrazinamide

- Hydrazine Derivatives

- Miscellaneous Anti-Tubercular Drugs

- Ethambutol

Based on the Application:

- Ambulatory Surgical Centers

- Hospital Pharmacies

- Individual Pharmacies

COVID-19 Impact on Tuberculosis Therapeutics Market, Global Research Reports 2020-2021

Table of Contents
1.1 Research Scope
1.2 Market Segmentation
1.3 Research Objectives
1.4 Research Methodology
1.4.1 Research Process
1.4.2 Data Triangulation
1.4.3 Research Approach
1.4.4 Base Year
1.5 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
1.5.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
1.5.2 Covid-19 Impact: Commodity Prices Indices
1.5.3 Covid-19 Impact: Global Major Government Policy
1.6 The Covid-19 Impact on Tuberculosis Therapeutics Industry
1.7 COVID-19 Impact: Tuberculosis Therapeutics Market Trends
2 Global Tuberculosis Therapeutics Quarterly Market Size Analysis
2.1 Tuberculosis Therapeutics Business Impact Assessment - COVID-19
2.1.1 Global Tuberculosis Therapeutics Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
2.2 Global Tuberculosis Therapeutics Quarterly Market Size 2020-2021
2.3 COVID-19-Driven Market Dynamics and Factor Analysis
2.3.1 Drivers
2.3.2 Restraints
2.3.3 Opportunities
2.3.4 Challenges
3 Quarterly Competitive Assessment, 2020
3.1 By Players, Global Tuberculosis Therapeutics Quarterly Market Size, 2019 VS 2020
3.2 By Players, Tuberculosis Therapeutics Headquarters and Area Served
3.3 Date of Key Players Enter into Tuberculosis Therapeutics Market
3.4 Key Players Tuberculosis Therapeutics Product Offered
3.5 Mergers & Acquisitions, Expansion Plans
4 Impact of Covid-19 on Tuberculosis Therapeutics Segments, By Type
4.1 Introduction
1.4.1 Isoniazid
1.4.2 Rifampin
1.4.3 Pyrazinamide
1.4.4 Hydrazine Derivatives
1.4.5 Miscellaneous Anti-Tubercular Drugs
1.4.6 Ethambutol
4.2 By Type, Global Tuberculosis Therapeutics Market Size, 2019-2021
5 Impact of Covid-19 on Tuberculosis Therapeutics Segments, By Application
5.1 Overview
5.5.1 Ambulatory Surgical Centers
5.5.2 Hospital Pharmacies
5.5.3 Individual Pharmacies
5.2 By Application, Global Tuberculosis Therapeutics Market Size, 2019-2021
5.2.1 By Application, Global Tuberculosis Therapeutics Market Size by Application, 2019-2021
6 Geographic Analysis
6.1 Introduction
6.2 North America
6.2.1 Macroeconomic Indicators of US
6.2.2 US
6.2.3 Canada
6.3 Europe
6.3.1 Macroeconomic Indicators of Europe
6.3.2 Germany
6.3.3 France
6.3.4 UK
6.3.5 Italy
6.4 Asia-Pacific
6.4.1 Macroeconomic Indicators of Asia-Pacific
6.4.2 China
6.4.3 Japan
6.4.4 South Korea
6.4.5 India
6.4.6 ASEAN
6.5 Rest of World
6.5.1 Latin America
6.5.2 Middle East and Africa
7 Company Profiles
7.1 Aventis Pharmaceuticals
7.1.1 Aventis Pharmaceuticals Business Overview
7.1.2 Aventis Pharmaceuticals Tuberculosis Therapeutics Quarterly Revenue, 2020
7.1.3 Aventis Pharmaceuticals Tuberculosis Therapeutics Product Introduction
7.1.4 Aventis Pharmaceuticals Response to COVID-19 and Related Developments
7.2 Sanofi -Aventis
7.2.1 Sanofi -Aventis Business Overview
7.2.2 Sanofi -Aventis Tuberculosis Therapeutics Quarterly Revenue, 2020
7.2.3 Sanofi -Aventis Tuberculosis Therapeutics Product Introduction
7.2.4 Sanofi -Aventis Response to COVID-19 and Related Developments
7.3 Versapharma Incorporated
7.3.1 Versapharma Incorporated Business Overview
7.3.2 Versapharma Incorporated Tuberculosis Therapeutics Quarterly Revenue, 2020
7.3.3 Versapharma Incorporated Tuberculosis Therapeutics Product Introduction
7.3.4 Versapharma Incorporated Response to COVID-19 and Related Developments
7.4 Sigma Pharmaceutical Pty
7.4.1 Sigma Pharmaceutical Pty Business Overview
7.4.2 Sigma Pharmaceutical Pty Tuberculosis Therapeutics Quarterly Revenue, 2020
7.4.3 Sigma Pharmaceutical Pty Tuberculosis Therapeutics Product Introduction
7.4.4 Sigma Pharmaceutical Pty Response to COVID-19 and Related Developments
7.5 Novartis AG
7.5.1 Novartis AG Business Overview
7.5.2 Novartis AG Tuberculosis Therapeutics Quarterly Revenue, 2020
7.5.3 Novartis AG Tuberculosis Therapeutics Product Introduction
7.5.4 Novartis AG Response to COVID-19 and Related Developments
7.6 Hoffmann-La Roche
7.6.1 Hoffmann-La Roche Business Overview
7.6.2 Hoffmann-La Roche Tuberculosis Therapeutics Quarterly Revenue, 2020
7.6.3 Hoffmann-La Roche Tuberculosis Therapeutics Product Introduction
7.6.4 Hoffmann-La Roche Response to COVID-19 and Related Developments
7.7 Bayer Health Care
7.7.1 Bayer Health Care Business Overview
7.7.2 Bayer Health Care Tuberculosis Therapeutics Quarterly Revenue, 2020
7.7.3 Bayer Health Care Tuberculosis Therapeutics Product Introduction
7.7.4 Bayer Health Care Response to COVID-19 and Related Developments
8 Key Findings
9 Appendix
9.1 About US
9.2 Disclaimer
List of Tables
Table 1. Overview of the World Economic Outlook Projections
Table 2. Summary of World Real per Capita Output (Annual percent change; in international currency at purchasing power parity)
Table 3. European Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 4. Asian and Pacific Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 5. Western Hemisphere Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 6. Middle Eastern and Central Asian Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 7. Covid-19 Impact: Global Major Government Policy
Table 8. The Covid-19 Impact on Tuberculosis Therapeutics Assessment
Table 9. COVID-19 Impact: Tuberculosis Therapeutics Market Trends
Table 10. COVID-19 Impact Global Tuberculosis Therapeutics Market Size
Table 11. Global Tuberculosis Therapeutics Quarterly Market Size, 2020 (US$ Million)
Table 12. Global Tuberculosis Therapeutics Market Size, Pre-COVID-19 and Post- COVID-19 Quarterly Comparison, 2020-2021 (US$ Million)
Table 13. Global Tuberculosis Therapeutics Market Growth Drivers
Table 14. Global Tuberculosis Therapeutics Market Restraints
Table 15. Global Tuberculosis Therapeutics Market Opportunities
Table 16. Global Tuberculosis Therapeutics Market Challenges
Table 17. By Players, Tuberculosis Therapeutics Quarterly Revenue, 2019 VS 2020 (US$ Million)
Table 18. Key Players, Tuberculosis Therapeutics Revenue Market Share, 2019 VS 2020 (%)
Table 19. Key Tuberculosis Therapeutics Players Headquarters and Area Served
Table 20. Date of Key Players Enter into Tuberculosis Therapeutics Market
Table 21. Key Players Tuberculosis Therapeutics Product Type
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. By Players, Global Tuberculosis Therapeutics Market Size 2019-2021, (US$ Million)
Table 24. Global Tuberculosis Therapeutics Market Size by Application: 2019-2021 (US$ Million)
Table 25. Global Tuberculosis Therapeutics Market Size by Region, 2019-2021 (US$ Million)
Table 26. By Country, North America Tuberculosis Therapeutics Market Size, 2019-2021 (US$ Million)
Table 27. By Type, US Tuberculosis Therapeutics Market Size, 2019-2021 (US$ Million)
Table 28. By Application, US Tuberculosis Therapeutics Market Size, 2019-2021 (US$ Million)
Table 29. By Type, Canada Tuberculosis Therapeutics Market Size, 2019-2021 (US$ Million)
Table 30. By Application, Canada Tuberculosis Therapeutics Market Size, 2019-2021 (US$ Million)
Table 31. Macroeconomic Indicators of Europe (Germany, France, UK and Italy)
Table 32. By Country, Europe Tuberculosis Therapeutics Market Size, 2019-2021 (US$ Million)
Table 33. By Type, Germany Tuberculosis Therapeutics Market Size, 2019-2021 (US$ Million)
Table 34. By Application, Germany Tuberculosis Therapeutics Market Size, 2019-2021 (US$ Million)
Table 35. By Type, France Tuberculosis Therapeutics Market Size, 2019-2021 (US$ Million)
Table 36. By Application, France Tuberculosis Therapeutics Market Size, 2019-2021 (US$ Million)
Table 37. By Type, UK Tuberculosis Therapeutics Market Size, 2019-2021 (US$ Million)
Table 38. By Application, UK Tuberculosis Therapeutics Market Size, 2019-2021 (US$ Million)
Table 39. By Type, Italy Tuberculosis Therapeutics Market Size, 2019-2021 (US$ Million)
Table 40. By Application, Italy Tuberculosis Therapeutics Market Size, 2019-2021 (US$ Million)
Table 41. Macroeconomic Indicators of Asia-Pacific (China, Japan, South Korea, India and ASEAN)
Table 42. By Region, Asia-Pacific Tuberculosis Therapeutics Market Size, 2019-2021 (US$ Million)
Table 43. By Type, China Tuberculosis Therapeutics Market Size, 2019-2021 (US$ Million)
Table 44. By Application, China Tuberculosis Therapeutics Market Size, 2019-2021 (US$ Million)
Table 45. By Type, Japan Tuberculosis Therapeutics Market Size, 2019-2021 (US$ Million)
Table 46. By Application, Japan Tuberculosis Therapeutics Market Size, 2019-2021 (US$ Million)
Table 47. By Type, South Korea Tuberculosis Therapeutics Market Size, 2019-2021 (US$ Million)
Table 48. By Application, South Korea Tuberculosis Therapeutics Market Size, 2019-2021 (US$ Million)
Table 49. By Type, India Tuberculosis Therapeutics Market Size, 2019-2021 (US$ Million)
Table 50. By Application, India Tuberculosis Therapeutics Market Size, 2019-2021 (US$ Million)
Table 51. By Type, ASEAN Tuberculosis Therapeutics Market Size, 2019-2021 (US$ Million)
Table 52. By Application, ASEAN Tuberculosis Therapeutics Market Size, 2019-2021 (US$ Million)
Table 53. By Type, Latin America Tuberculosis Therapeutics Market Size, 2019-2021 (US$ Million)
Table 54. By Application, Latin America Tuberculosis Therapeutics Market Size, 2019-2021 (US$ Million)
Table 55. By Type, Middle East and Africa Tuberculosis Therapeutics Market Size, 2019-2021 (US$ Million)
Table 56. By Application, Middle East and Africa Tuberculosis Therapeutics Market Size, 2019-2021 (US$ Million)
Table 57. Aventis Pharmaceuticals Business Overview
Table 58. Aventis Pharmaceuticals Tuberculosis Therapeutics Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 59. Aventis Pharmaceuticals Tuberculosis Therapeutics Product
Table 60. Aventis Pharmaceuticals Response to COVID-19 and Related Developments
Table 61. Sanofi -Aventis Business Overview
Table 62. Sanofi -Aventis Tuberculosis Therapeutics Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 63. Sanofi -Aventis Tuberculosis Therapeutics Product
Table 64. Sanofi -Aventis Response to COVID-19 and Related Developments
Table 65. Versapharma Incorporated Business Overview
Table 66. Versapharma Incorporated Tuberculosis Therapeutics Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 67. Versapharma Incorporated Tuberculosis Therapeutics Product
Table 68. Versapharma Incorporated Response to COVID-19 and Related Developments
Table 69. Sigma Pharmaceutical Pty Business Overview
Table 70. Sigma Pharmaceutical Pty Tuberculosis Therapeutics Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 71. Sigma Pharmaceutical Pty Tuberculosis Therapeutics Product
Table 72. Sigma Pharmaceutical Pty Response to COVID-19 and Related Developments
Table 73. Novartis AG Business Overview
Table 74. Novartis AG Tuberculosis Therapeutics Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 75. Novartis AG Tuberculosis Therapeutics Product
Table 76. Novartis AG Response to COVID-19 and Related Developments
Table 77. Hoffmann-La Roche Business Overview
Table 78. Hoffmann-La Roche Tuberculosis Therapeutics Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 79. Hoffmann-La Roche Tuberculosis Therapeutics Product
Table 80. Hoffmann-La Roche Response to COVID-19 and Related Developments
Table 81. Bayer Health Care Business Overview
Table 82. Bayer Health Care Tuberculosis Therapeutics Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 83. Bayer Health Care Tuberculosis Therapeutics Product
Table 84. Bayer Health Care Response to COVID-19 and Related Developments
List of Figures
Figure 1. Tuberculosis Therapeutics Product Picture
Figure 2. Tuberculosis Therapeutics Market Segmentation
Figure 3. Research Objectives
Figure 4. Research Process
Figure 5. Data Triangulation
Figure 6. Research Approach
Figure 7. Commodity Prices-Metals Price Indices
Figure 8. Commodity Prices- Precious Metal Price Indices
Figure 9. Commodity Prices- Agricultural Raw Material Price Indices
Figure 10. Commodity Prices- Food and Beverage Price Indices
Figure 11. Commodity Prices- Fertilizer Price Indices
Figure 12. Commodity Prices- Energy Price Indices
Figure 13. G20+: Economic Policy Responses to COVID-19
Figure 14. Global Tuberculosis Therapeutics Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026 (US$ Million)
Figure 15. Global Tuberculosis Therapeutics Market Size, Pre-COVID-19 and Post- COVID-19, Year-over-Year Growth Rate, 2015-2026 (%)
Figure 16. Global Tuberculosis Therapeutics Market Size, Quarterly Growth, 2020-2021 (%)
Figure 17. Global Tuberculosis Therapeutics Market Size, Market Share by Type, 2019 VS 2020 (%)
Figure 18. Global Tuberculosis Therapeutics Market Size, Market Share by Application, 2019 VS 2020 (%)
Figure 19. Global Tuberculosis Therapeutics Market Size Market Share by Region, 2019 VS 2020 (%)
Figure 20. United States Composite PMI and GDP
Figure 21. Eurozone Composite PMI and GDP
Figure 22. Eurozone Core v. Periphery PMI Output Indices
Figure 23. Core v. Periphery PMI Employment Indices
Figure 24. UK Composite PMI and GDP
Figure 25. Caixin China Composite Output Index
Figure 26. Caixin China General Services Business Activity Index
Figure 27. Japan Composite Output Index
Figure 28. South Korea Manufacturing PMI
Figure 29. India Composite Output Index
Figure 30. ASEAN Manufacturing PMI
Figure 31. By Region, Asia-Pacific Tuberculosis Therapeutics Market Size Market Share, 2019-2021
  • COVID-19 Impact on Global Water Picks Market Insights, Forecast to 2026
    Published: 04-Jun-2020        Price: US 4900 Onwards        Pages: 113
    Water Picks market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Water Picks market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on production capacity, revenue and forecast by Type and by Application for the period 2015-2026. Segment by Type, the Water Picks market is segmented into Fixed Frequency Variable Freq......
  • COVID-19 Impact on Global Electric Water Picks Market Insights, Forecast to 2026
    Published: 04-Jun-2020        Price: US 4900 Onwards        Pages: 114
    Electric Water Picks market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Electric Water Picks market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on production capacity, revenue and forecast by Type and by Application for the period 2015-2026. Segment by Type, the Electric Water Picks market is segmented into Fixed Frequen......
  • COVID-19 Impact on Global Dental Calculus Remover Market Insights, Forecast to 2026
    Published: 04-Jun-2020        Price: US 4900 Onwards        Pages: 113
    Dental Calculus Remover market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Dental Calculus Remover market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on production capacity, revenue and forecast by Type and by Application for the period 2015-2026. Segment by Type, the Dental Calculus Remover market is segmented into Manu......
  • COVID-19 Impact on Global Nuclear Magnetic Resonance Hardware Market Insights, Forecast to 2026
    Published: 04-Jun-2020        Price: US 4900 Onwards        Pages: 118
    Nuclear Magnetic Resonance Hardware market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Nuclear Magnetic Resonance Hardware market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on production capacity, revenue and forecast by Type and by Application for the period 2015-2026. Segment by Type, the Nuclear Magnetic Resonance Hardware market is segmented ......
  • COVID-19 Impact on Global NMR Spectroscopy Market Insights, Forecast to 2026
    Published: 04-Jun-2020        Price: US 4900 Onwards        Pages: 113
    NMR Spectroscopy market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global NMR Spectroscopy market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on production capacity, revenue and forecast by Type and by Application for the period 2015-2026. Segment by Type, the NMR Spectroscopy market is segmented into 45 MHz 60 MHz......
  • COVID-19 Impact on Global Pulsed NMR Market Insights, Forecast to 2026
    Published: 04-Jun-2020        Price: US 4900 Onwards        Pages: 111
    Pulsed NMR market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Pulsed NMR market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on production capacity, revenue and forecast by Type and by Application for the period 2015-2026. Segment by Type, the Pulsed NMR market is segmented into Sub-100MHz 300-400 MHz ......
  • COVID-19 Impact on Global Medical Processing Seals Market Insights, Forecast to 2026
    Published: 04-Jun-2020        Price: US 4900 Onwards        Pages: 112
    Medical Processing Seals market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Medical Processing Seals market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on production capacity, revenue and forecast by Type and by Application for the period 2015-2026. Segment by Type, the Medical Processing Seals market is segmented into O......
  • COVID-19 Impact on Global Neurovascular or Interventional Neurology Devices Market Insights, Forecast to 2026
    Published: 04-Jun-2020        Price: US 4900 Onwards        Pages: 112
    Neurovascular or Interventional Neurology Devices market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Neurovascular or Interventional Neurology Devices market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on production capacity, revenue and forecast by Type and by Application for the period 2015-2026. Segment by Type, the Neurovascular or Interventio......
  • COVID-19 Impact on Global VCSEL Laser Market Insights, Forecast to 2026
    Published: 04-Jun-2020        Price: US 4900 Onwards        Pages: 110
    VCSEL Laser market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global VCSEL Laser market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on production capacity, revenue and forecast by Type and by Application for the period 2015-2026. Segment by Type, the VCSEL Laser market is segmented into Single-mode VCSEL Multimode V......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs